|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 47/42 | |
| A61K 47/64 | |||
| A61K 39/00 | |||
| C07K 17/14 | |||
| C12N 5/00 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2376110 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10729571.9 |
| Europos patento paraiškos padavimo data | 2010-01-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-10-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-03-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/020504 |
| Data | 2010-01-08 |
| (87) | Numeris | WO 2010/081004 |
| Data | 2010-07-15 |
| (30) | Numeris | Data | Šalis |
| 143713 P | 2009-01-09 | US | |
| 152205 P | 2009-02-12 | US | |
| 175719 P | 2009-05-05 | US | |
| 264222 P | 2009-11-24 | US |
| (72) |
SIEVERS, Eric, US
KENNEDY, Dana, US
IHLE, Nathan, US
SUN, Michael, US
|
| (73) |
Seattle Genetics, Inc.,
21823 30th Drive, S.E., Bothell, WA 98021,
US
|
| (54) | WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES |
| WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES |